 |
Dr. Don Rix, Chairman of the Board
Dr. Rix is the founder and Chairman of MDS Metro Laboratory Services, which was sold to OMERS for $1.4 billion in 2007. Dr. Rix received the Order of Canada in 2007 for his contributions to the life science industry. |
| |
|
 |
Frank Holler, Director
Frank Holler was the founding CEO of ID Biomedical, which was sold to GlaxoSmithKline in 2006 for $1.6 billion. He is also the founding Director of Angiotech Pharmaceuticals and the founding CEO of Xenon Pharmaceuticals. |
| |
|
 |
Dr. Avtar Dhillon, Director
Dr. Avtar Dhillon is the President and CEO of Inovio Biomedical. Prior to joining Inovio, Dr. Dhillon was Vice President of MDS Capital Corp., one of North America’s leading healthcare venture capital organizations. |
| |
|
 |
Brad Bennett, Director
Brad Bennett is President of McIntosh Properties Ltd., a real estate investment and holding company based in Kelowna. Brad is Chair of UBC's Board of Governors and a Director of the Premier's Technology Council. |
| |
|
 |
Randy Buchamer, Director
Randy Buchamer is the CEO of Voice Mobility International. Randy started and sold a software development distribution company; was the Chief Operating Officer for Mohawk Oil, a $400 million western based retailer; and was the Director of Operations for the $4 billion Jim Pattison Group. |
| |
|
 |
David Shore, Director
David Shore is a partner of Stirling Mercantile Corporation, a Vancouver based investment bank established in 1998. At Stirling, David helps emerging technology companies complete equity and debt financings. |
| |
|
 |
Derek Spratt, Director
Derek Spratt is currently President & CEO of Mobidia Derek is the founder of Intrinsyc Software and previously served as its CEO. Prior to Intrinsyc, Derek was a co-founder and CEO of Consequent Technologies and a co-founder and EVP of PCS Wireless Inc. |
